By Phase

Early Phase

Dynamic strategy and faster timeline to move your early phase clinical research from First-in-Human to Proof-of-Concept.










Your Early Phase Clinical Trial Partner for Navigating Early Clinical Studies

Early clinical development typically refers to Phase I and Phase IIa studies, which investigate the safety, tolerability and pharmacokinetic (PK) / pharmacodynamic (PD) properties of an investigational drug, and explore its efficacy. At Tigermed, our specialized Early Phase team is dedicated to providing tailored early phase clinical services for navigating this challenging phase of clinical development. From First-in-Human to Proof-of-Concept programs, we enable your product from concept to compound to cure.

Phase I / First-in-Human

As a Phase I CRO, our teams collaborate closely with you to develop tailored roadmaps for your Phase I clinical trials and aim to maximize efficiency, anticipate challenges, and mitigate risk. Our Phase I strategies minimize the time spent on reaching a key go/no-go decision by leveraging our many early phase research facilities, biometrics capabilities, PK/PD study experts, and project management experience.

Phase IIa / Proof-of-Concept

We always start with the end in mind, and successful early phase trial management requires a high degree of flexibility to answer questions early and avoid unnecessary investment at a later stage. Additionally, we have a proven track record of enrolling suitable and usually hard-to-find patients for specialized trials thanks to our dedicated recruitment centers.

Integrated Platform.
Tailored Solutions.

We incorporate scientific excellence and product development strategy with expertise in early phase clinical research, pharmacology, PK/PD modeling & simulation, and the full range of early phase trial support.

Early Clinical Capabilities & Experience

As an early phase CRO, we bring an integrated team of regulatory, pharmacology, and medical science experts to inform the doses of the drugs, safety selection, and PK/PD evaluation. We help design a protocol that works smarter for you, generating the data you’ll need to inform decision-making.

Why Partner with Us for Early Phase Drug Development

  • Customized Strategy

    Providing tailored development strategy and protocol design, as part of our early phase services, to fit your scientific and regulatory needs.

  • One-stop Solutions

    A dedicated early phase clinical trial management team to deliver the right combination of in-house resources, tools and expertise.

  • Collaborative Sites

    A wide network of collaborative early phase sites and subjects.

  • PK/PD Modeling & Simulation

    50+ professionals in pharmacokinetic and pharmacodynamic modeling and simulation

Including China into Your Global Drug Development Strategy










Get in Contact

Please complete the form below to submit your request or questions. Our representative will respond promptly